Mahoney said the company’s growth strategy “has long centered on category leadership” across the medical specialties it serves, and he pointed to what he described as strong 2025 execution. Mahoney reported that Boston Scientific generated $20 billion in net sales in 2025 and delivered mid-teens growth . He added that the company invested more than $2 billion in research and development, expanded its global reach to 127 countries , and operated with approximately 59,000 employees worldwide . Mahoney also sa ...